Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Intentional mixture of two or more micro-organisms, cells, or viruses of different genera

Subclass of:

424 - Drug, bio-affecting and body treating compositions

424930100 - WHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAINING

Patent class list (only not empty are listed)

Deeper subclasses:

Entries
DocumentTitleDate
20080260694Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - The invention relates to multipotential expanded mesenchymal precursor progeny (MEMP's), characterised by the early developmental markers STRO-110-23-2008
20090324550COMPOSITION AND METHOD FOR INHIBITION OF MICROORGANISMS - A composition and method for the inhibition of microorganisms.12-31-2009
20100086520Compositions, Kits and Uses For Protecting The Skin Against Pathogenic Microorganisms - Described are compositions and kits comprising: (i) microorganisms which are able to stimulate the growth of microorganisms of the resident skin microbial flora and which do not stimulate the growth of microorganisms of the transient pathogenic micro flora and (ii) microorganisms which are able to inhibit the growth of one or more microorganisms of the transient pathogenic skin micro flora and which do not inhibit the growth of microorganisms of the healthy normal resident skin micro flora, in order to protect the skin against pathogenic microorganisms and to treat skin diseases. The present invention also relates to uses of the above mentioned microorganisms and to methods for the production of compositions and kits comprising such microorganisms.04-08-2010
20100119487CULTURE MEDIUM FOR LACTOBACILLUS ACIDOPHILUS AND STREPTOCOCCUS FAECALIS, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD THEREOF - The present invention provides a triple vital bacteria composition, including: powder of 05-13-2010
20100119486ANTIBACTERIAL TREATMENT METHOD - Disclosed is an antibacterial treatment method which has no limitation in the scope of a material to be treated and which enables to reduce the time or cost required for the antibacterial testament. Specifically disclosed is an antibacterial treatment method using an antibacterial agent comprising a powder produced by mixing a microorganism selected from 05-13-2010
20120244125BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL - The present invention generally relates to the field of weight management. The present invention relates for example to the use of 09-27-2012
20120244124PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS - A method of combating rheumatoid arthritis, comprising administering to a human subject in need thereof, an effective oral dose of a probiotic composition in an oral dose form including, as the only bacterial species therein, the bacterial species of 09-27-2012
20120183504COMPOSITION AND USE OF PROBIOTIC STRAIN GM-263 (ADR-1) IN TREATING RENAL FIBROSIS IN DIABETES - A use of probiotic strain GM-263 (ADR-1) in treating renal fibrosis in diabetes is disclosed. The probiotic strain such as 07-19-2012
20120207712Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin - The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which perform correct, effective colonisation of the probiotic components administered, with enteric consequences which involve maintaining and/or restoring intestinal health and preventing the consequences of common dysbioses of the digestive tract caused by stress, incorrect dietary habits and antibiotic treatments. Said compositions also have a concomitant anti-inflammatory and immunomodulating action.08-16-2012
20130045185STRAINS AND METHODS USEFUL FOR MYCOTOXINS - The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are 02-21-2013
20090155216Grafting Material and Agent for Improvement in bone Quality - The present invention has an object to provide a transplant material allowing systemic bone substance improvement to be realized by cell transplant. The present invention teaches to use a transplant material comprising a cell selected from the group consisting of an embryonic stem cell, a mesenchymal stem cell, an osteoblast cell, a preosteoblast, a chondrocyte and a cell having a capability of bone formation through systemic or topical administration for the improvement in bone quality.06-18-2009
20100040579PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION F ILLNESS - The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions suitable for preventing disease in young children. In some particularly preferred embodiments, the present invention finds use in the prevention respiratory disease in children.02-18-2010
20080253999Methods For Differentiating Stem Cells and Uses Thereof in the Treatment of Dental Conditions - The present invention relates to a method for propagating and/or differentiating mammalian cells, the method comprising exposing or co-culturing mammalian cells with one or more of periodontal ligament tissue, periodontal ligament proteins or factors derived from periodontal ligament tissue, to obtain cells having PDL characteristics and fulfilling at least one of the following: 10-16-2008
20100143306USE OF BONE MARROW CELLS FOR LONG TERM CULTURE OF PANCREATIC ISLET CELLS - Bone marrow cells have been demonstrated to be useful in the maintenance of pancreatic islet β cell viability, structure, and/or function in culture for a sustained period. Bone marrow cells were also found to promote β cell growth while reducing inflammatory cytokine release and reduce apoptosis. Moreover, islet cells co-cultured with bone marrow cells were shown to retain insulin response function and to function in an islet cell transplant in a mouse model of diabetes to restore normal insulin secretion. Cord blood cells and isolated peripheral CD34+ blood cells were unable to support β islet cell growth or increase survival.06-10-2010
20100330040COMPOSITION WITH SYNBIOTICS - Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.12-30-2010
20130089524L. JOHNSONII LA1, B. LONGUM NCC2705 AND IMMUNE DISORDERS - The present invention generally relates to the field of probiotics, and in particular to preventing and/or treating inflammatory and infectious disorders, for example by boosting the endogenous antimicrobial defences. One embodiment of the present invention is a composition comprising a combination of 04-11-2013
20130064795IMMUNE MODULATION - The invention provides a layered double hydroxide compound for use in modulating an immune response to an antigen, and an immune modulator composition comprising the layered double hydroxide and an antigen. The compound is of formula (I), (II), or (III)03-14-2013
20130064796METHODS FOR THE PREVENTION AND CONTROL OF PATHOGENIC INFECTIONS IN BEES AND RELATIVE COMPOSITION - The invention relates to a probiotic mixture for the protection of bees' health, and more specifically for the protection from microbial pathologies, such as those caused by 03-14-2013
20090238796Preparation for treatment of non-infectious inflammatory intestinal diseases - The invention relates to medicine and can be used for treating non-infectious inflammatory intestinal diseases to enhance efficiency of the non-infectious inflammatory intestinal disease treatment and reduce the length, the inventive preparation contains 5-aminosalicylic acid (5 ASA) or a substance, which decomposes in the organism that 5 ASA is formed, and a liophylically dried microbial mass of live bifido- or lactobacteria or the mixture, said bacteria can be immobilised on a sorbent. The 5 ASA can be powdered or granulated mesalazine or sulphasalazine. To ease the administration of preparation and ensure the dilution of components in defined sectors of the gastrointestinal tract, said components can be grouped in two capsules that jointly represent a single dose, wherein one capsule contains a microbial mass of live bacteria and the other capsule contains mesalazine or sulphasalazine or the capsule containing microbial mass of live bacteria is arranged in the mesalazine or sulphasalazine-containing capsule.09-24-2009
20110044950Infusion of a Mixture of Autologous Bone Marrow-Derived Mononuclear Cells and Autologous or Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Treating Myocardial and/or Cardiovascular Disorders - The present invention is a method for improving cardiac and/or cardiovascular functions in living subjects after the occurrence of a myocardial and/or cardiovascular disorder, involving tissue damage and/or an ischemic event. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow-derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged tissue. Studies have shown that the implant improves blood perfusion in an ischemic tissue and thus contributes to the recovery of cardiac and/or cardiovascular function as assessed by methods of choice, including magnetic resonance imaging (“MRI”), echocardiography, angiography and 99mTc-TF perfusion scintigraphy.02-24-2011
20120114609BIOLOGICAL MATERIAL SUITABLE FOR THE THERAPY OF OSTEOARTHROSIS, LIGAMENT DAMAGE AND FOR THE TREATMENT OF JOINT DISORDERS - The present invention regards a biological material comprising: a) a liquid carrier comprising a viscous solution containing at least one natural and/or semisynthetic polysaccharide, and having a Dynamic viscosity measured at 20° C. and at shear rate of D=350 s05-10-2012
20120114608COMPOSITIONS, METHODS AND KITS FOR ENHANCING IMMUNE RESPONSE TO A RESPIRATORY CONDITION - Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. Also included are methods of treating a respiratory condition, preferably by enhancing immune response, in a mammal. Kits containing the compositions, and instructions for applying the methods are also included. The method includes orally administering to the mammal a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component.05-10-2012
20120009155Prebiotic Composition for Increasing Probiotic Growth Rate and Activity - Sunflower lecithin or sunflower lecithin with oleic acid stimulate the growth and lactic acid producing activity of 01-12-2012
20110280839Entomopathogenic Fungi and Uses Thereof - The present invention provides a strain of entomopathogenic 11-17-2011
20110280838TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS - Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells and optionally a hydrogel. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.11-17-2011
20110280837BIFIDOBACTERIUM LONGUM AND HIPPOCAMPAL BDNF EXPRESSION - The present invention relates in general to edible compositions comprising probiotics. One embodiment of the present invention relates to an edible composition comprising 11-17-2011
20110293569LACTOBACILLUS RHAMNOSUS CNCM I-4096 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of 12-01-2011
20110293568LACTOBACILLUS HELVETICUS CNCM I-4095 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of 12-01-2011
20090110663Method for treatment of bowel disorders - A composition and method for treatment for bowel disorders is described. The composition consists of two parts. First, highly purified, insoluble, chemically unmodified fiber from plants is mixed with an aqueous solution such as water. The second component of the composition is a commercially available probiotic preparation. These commercially probiotic preparations contain large numbers of viable microorganisms of either 04-30-2009
20090092584BIO DEGRADATION OF OXYANIONS SUCH AS PERCHLORATE ON ION EXCHANGE RESINS - Systems and methods for removing perchlorate load off of ion exchange resins are disclosed. The systems and methods rely upon direct contact between the resin and a liquid product formed by the culturing of perchlorate-destroying microorganisms. These methods can be incorporated into methods for removing perchlorate from aqueous streams. A resin product comprising an anion exchange resin with a coating of perchlorate-destroying microorganisms on its surface is also disclosed.04-09-2009
20110300108Herbal Compositions for the Control of Hematophagous Parasites - There is described an herbal hematophagous parasite control composition which comprises 12-08-2011
20120294833STRAINS OF LACTIC ACID BACTERIA FOR PREVENTING NECROTIZING ENTEROCOLITIS - The present invention relates to novel strains of lactic acid bacteria, 11-22-2012
20090274660PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF - Synthetic Stem Cell-like Tissue Healing and Regeneration Medication with Anti-inflammatory, Protein Synthesis, Enzyme Deficiency Activation and Genetic Therapy, and Anti-cancer Agent derived from a series of inventions that include these products of Biomolecular Engineering, Drug Discovery from a Biologic Periodic Table of Applied Biochemistry and Biophysics. Tissue has a self healing effect promoting tissue healing and tissue regeneration. Not only does it maintain good health but also it has been observed that the patient's blood is withdrawn from the patient and applied to the ulcer has healing qualities. Cartilage placed in a wound promotes and accelerates wound healing. The anabolic biochemical and biophysical equivalent of tissue has been found in these embodiments to have the same pharmacologic qualities, when devoid of genetic DNA mismatch and other catabolic factors including the catabolic effects of microorganism overgrowth that lacks pro-biotic qualities. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.11-05-2009
20120183505ARTIFICIAL DERMIS AND METHOD OF PREPARATION - Artificial dermis (07-19-2012
20110200561Method for Bacteriophage Delivery and Amplification - Disclosed are methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected by the methods. Also disclosed are methods of treating a subject infected with a pathogenic bacterium using bacteriophage and methods of decontaminating objects using bacteriophage. Also disclosed are methods of producing vaccines. In another aspect, methods of determining bacterial viability and methods of improving the sensitivity of a biosensor using wide host range bacteriophages are disclosed.08-18-2011
20090297481ANIMAL FEED SUPPLEMENTS AND USES THEREOF - Described feed supplement compositions containing beneficial viable microorganisms and potentially other beneficial nonviable materials, and methods of use thereof.12-03-2009
20090252708Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof - Biotherapeutic compositions of a non-pathogenic bacterial strain such as M-17 and its substrains and an anaerobic bacterial antibiotic such as metronidazole, are disclosed. Further disclosed are uses of M-17 or its substrains and an anaerobic bacterial antibiotic for treating disorders caused by anaerobic bacteria, whereby such disorders include, for example, pouchitis, microbial infection, irritable bowel syndrome, inflammatory bowel disease, mucous colitis and diarrhea.10-08-2009
20110223137COMPOSITIONS FOR USE IN LOW-BIRTH WEIGHT INFANTS - The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in low birth weight infants. The invention is also concerned with the use of specific probiotics in the manufacture of low-birth weight infant formulations.09-15-2011
20100266549NOVEL PROBIOTICS FOR PET FOOD APPLICATIONS - The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions containing the same.10-21-2010
20100226892USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION - Disclosed are methods directed to the cosmetic use of an effective amount of at least one probiotic microorganism especially from the genus 09-09-2010
20100196323Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof - The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group 08-05-2010
20110117059COMPOSITION OF SOLUBLE INDIGESTIBLE FIBRE AND OF MICROALGAE USED IN THE WELL-BEING FIELD - Described is the use of soluble indigestible fibre for inducing lysis of the cell walls of eukaryotic microalgae in the lumen of the intestine of an omnivorous or carnivorous animal including an intestinal flora and also for synergistically increasing the effect of the indigestible fibre in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The subject matter of the invention is also the composition intended for this use and for a method of improving the health or of food supplementation.05-19-2011
20100310518Combinations of Flubendiamide and Beneficial Species - The novel combinations of flubendiamide and beneficial species comprising flubendiamide and at least one beneficial species from the orders or suborders of the Araneae, Acari, Dermaptera, Hymenoptera, Coleoptera, Neuroptera, Thysanoptera, Heteroptera, Diptera, Hemiptera, Dermaptera and/or Parasitiformes or at least one bacteria strain or at least one virus strain for the effective control of unwanted pests.12-09-2010
20110110894METHODS, COMPOSITIONS AND SYSTEMS FOR CONTROLLING FOULING OF A MEMBRANE - The present invention provides methods and compositions for improving permeability and flux in a membrane filtration system, especially in water or wastewater treatment processes.05-12-2011
20110033423PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS - The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms.02-10-2011
20120034190YEAST STRAINS AND THEIR USES IN THE PRODUCTION OF LIPIDS - The invention is directed to isolated microorganisms, as well as biomasses, cultures, microbial oils, and compositions thereof. The invention also provides methods of producing the microbial oils and methods of using the isolated microorganisms, biomasses, and microbial oils.02-09-2012
20090180990Composition for maintaining healthy kidney function - The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.07-16-2009
20110165127DAIRY-DERIVED PROBIOTIC COMPOSITIONS AND USES THEREOF - The present application relates to a dairy-derived probiotic composition comprising a propionic bacteria. The composition is particularly useful as a food supplement for normalizing the gastro-intestinal flora. The probiotic bacteria present in the composition contain species of 07-07-2011
20110020283PROBIOTIC, GRAM-POSITIVE BACTERIA FOR THE PROPHYLAXIS, SUPPRESSION, OR ELIMINATION OF ALLERGIC REACTIONS IN HUMANS - A pharmaceutical composition for the prophylaxis, suppression or elimination of allergic reactions in humans, includes probiotic, gram-positive bacteria, such as, for example, 01-27-2011
20100284972COMPOSITIONS AND METHODS FOR MAKING ALPHA-(1,2)-BRANCHED ALPHA-(1,6) OLIGODEXTRANS - Compositions for improving the health of a subject comprise alpha-(1,2)-branched alpha-(1,6) oligodextrans, preferably with an average molecular weight between about 10 kDa and 70 kDa, between about 10% and 50% alpha-(1,2)-osidic side chains, and having at least partial indigestibility in the subject. Methods for improving the health of a subject comprise administering the composition to a subject in an amount effective to improve gut health, or to prevent or treat a gastrointestinal disorder, a cholesterol-related disorder, diabetes, or obesity. Methods for making oligodextrans having controlled size and controlled degree of branching comprise providing alpha-(1,6) oligodextrans having an average molecular weight between 0.5 and 100 kDa and introducing at least 10% alpha-(1,2)-osidic side chains onto the alpha-(1,6) oligodextrans.11-11-2010
20110052537NITRO-BASED EXPLOSIVE REMEDIATION - Embodiments of techniques for remediating soil contaminated with compounds, particularly nitro-based explosives, are disclosed. Plants capable of taking up the compounds are grown within contaminated soil for a period of time. The plants are exposed to anaerobic microbes in the rumen of a ruminant animal. The ruminal anaerobic microbes degrade the remediable compounds and render them substantially nontoxic to the animal. In some embodiments, the remediable compounds are nitroaromatic compounds, and are degraded by nitroreductases. In other embodiments, microbes are transferred from a consortium enriched in microbes capable of degrading the remediable compounds to a ruminant animal that lacks microbes capable of degrading the remediable compounds. In other embodiments, methods for isolating and identifying ruminal anaerobic microbes capable of degrading remediable compounds are disclosed.03-03-2011
20100068184LIVING BODY HEALING ACCELERATOR - The present invention provides a living body healing, having an accelerating activity in the regeneration ability relating to the cure of damages of cells or tissues caused by toxicity of a drug or a wound in a living body, having high safety, and also not causing any side effect even administered for a long period of time. Problems are solved by a living body healing accelerator containing as an active constituent a mixture of a culture solution obtained after cultivation of a microorganism belonging to the 03-18-2010
20110189132MICROBIAL PRODUCT CONTAINING MULTIPLE MICROORGANISMS - Methods to reduce or inhibit populations of pathogenic bacteria in animals are disclosed. These methods include providing a number of administrations of probiotic microorganism compositions containing one or more strains or species of probiotic microorganisms. Routes of administration, dosage of administration and pathogenic organisms to be reduced or inhibited are also disclosed.08-04-2011
20100021430Horse feed and treatment methods - A horse feed mixture and method of treating a horse is disclosed. Feed mixtures disclosed contains more than 15% spelt, vegetable oil and vitamins and have less than 20% by weight fillers and less than 5% by weight sugar. The feed may be used to treat ailments including underweight condition, founder, colic, obesity, ulcers, inflammation, and chronic disease.01-28-2010
20120308524COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY - The invention provides a composition for use in therapy of lactose intolerance or conditions arising from lactase deficiency, wherein the composition is a non-dairy solid dosage form comprising: 12-06-2012
20120308523Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria - The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific 12-06-2012
20090148412METHODS OF USING A CHOLESTEROL-LOWERING PREPARATION, FOOD SUPPLEMENT AND FOODSTUFF - The present invention relates to cholesterol-lowering preparations, in particular to a bacterial preparation for use as a medicament for lowering of the blood cholesterol level. The present invention provides inter alia a preparation of 06-11-2009
20110305671Cell Compositions and Methods for Hair Follicle Generation - The application describes a method of generating a hair follicle, comprising administering a composition comprising epidermal matrix cells, dermal papilla cells, dermal sheath cells and outer root sheath cells to the scalp of a mammal. The composition may optionally be administered with a hair growth agent and/or a carrier. The application also describes a composition comprising epidermal matrix cells, dermal papilla cells, dermal sheath cells and outer root sheath cells and the use of the composition to generate hair follicles.12-15-2011
20100098667CULTURE MEDIUM FOR BIFIDOBACTERIUM LONGUM, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD - The present invention provides a triple vital bacteria composition, including: powder of 04-22-2010
20120039852LACTOBACILLUS RHAMNOSUS NCC4007, A PROBIOTIC MIXTURE AND WEIGHT CONTROL - The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of 02-16-2012
20100189692PROBIOTICS FOR USE IN REDUCING EOSINOPHILIA AND RESPIRATORY ALLERGIES - The present invention provides probiotic compositions suitable for reducing the incidence and duration of nasal eosinophilia and other parameters associated with birch pollen allergy. In some embodiments, the present invention provides methods and/or compositions suitable for reducing nasal and/or respiratory allergy symptoms.07-29-2010
20120003185BONE-LIKE PROSTHETIC IMPLANTS - A prosthetic implant comprising a biocompatible three-dimensional scaffold and at least two cell types selected from the group consisting of osteoblasts, osteoclasts, and endothelial cells or progenitors thereof.01-05-2012
20120009154Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition - Sunflower lecithin or sunflower lecithin with oleic acid stimulate the growth and lactic acid producing activity of 01-12-2012
20120156171COSMETIC AND/OR DERMATOLOGICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF SENSITIVE OR DRY SKIN - The invention relates to a cosmetic and/or dermatological topical composition, of particular use for the preventional and/or treatment of sensitive and/or dry skin, comprising an effective amount of at least one particularly probiotic microorganism and/or a fraction or metabolite thereof in combination with an effective amount of at least one polyunsaturated fatty acid and/or polyunsaturated fatty acid ester and/or a salt or derivative thereof in a physiologically-acceptable vehicle.06-21-2012
20120315249Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes - The invention provides a method and composition for ameliorating or reducing the symptoms, signs, and markers and for the treatment of irritable bowel syndrome, inflammatory bowel disease or gastritis in a mammal in need thereof, said method comprising administering effective amounts of a pharmaceutically acceptable composition containing at least one probiotic microorganism strain comprising 12-13-2012
20120128632IDENTITY MARKERS - Methods for identifying trichogenic dermal cells, including dermal papilla cells and dermal sheath cells, capable of inducing hair follicle formation when injected into skin are provided. It has been discovered that EGF latrophilin and seven transmembrane domain-containing protein 1 (ELTD1). Transmembrane Protein 108 (TMEM1 08), Hyaluronan and proteoglycan link protein 1 (HAPLN1) are biomarkers that can be used to detect, identify, and distinguish trichogenic dermal cells, i.e., that are able to induce hair follicle formation, from other skin cells. Populations of skin cells enriched with trichogenic dermal cells can be produced by selecting for and enriching for dermal cells that express ELTD1, TMEM1 08, HAPLN1, or a combination thereof.05-24-2012
20110182861COSMETIC USE OF MICROORGANISMS FOR THE TREATMENT OF OILY SKIN - The present invention relates to the cosmetic use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof, as an agent for treating and/or preventing oily skin or skin with an oily tendency and the associated skin disorders.07-28-2011
20110182860BIOCONTROL COMPOSITE MICROBIAL AGENT PSX COMBINATION FOR CONTROLLING SEVERAL SOIL-BORNE DISEASES AND ITS BACTERIOLOGICAL COMPOSITION - A composite biocontrol microbial agent PSX combination controls several soil-borne diseases. The PSX combination was composed of three biocontrol bacteria, which are shaking cultured in the PDA culture solution at 37° C., 180 rpm for 20 to 24 hours, then centrifugated at 4000 g for 10 min, taking the wet bacterium preserved fluid by the ratio of 1:40 to prepare the microbial agent, and then mixing at the ratio of 1:1:1, the total concentration of live bacteria in finished product being of 1×1007-28-2011
20120219526NUTRITIONAL COMPOSITIONS COMPRISING LACTOFERRIN AND PROBIOTICS AND KITS OF PARTS THEREOF - The present invention relates to nutritional composition for infants and/or children comprising lactoferrin and probiotics. These compositions have been found to be useful in providing health benefits in infants and/or children. A method of manufacture of these compositions is also part of the invention. These compositions may be in the form of a kit of parts wherein a first composition according to the invention and a second composition according to the invention are each adapted to fulfil the nutritional requirements in two different age groups.08-30-2012
20120134962METHODS AND COMPOSITIONS FOR TISSUE REGENERATION - Disclosed is a method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-Iβ, IL-6, IL-8, TGFα, and TNFα, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof.05-31-2012
20120134963COMPOSITIONS AND METHODS FOR ENHANCING VIRUS EFFICACY - Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.05-31-2012
20100172873STRAINS AND METHODS FOR IMPROVING RUMINANT HEALTH AND/OR PERFORMANCE - Described are strains including 07-08-2010
20120171162FERMENTED FOOD PRODUCTS CONTAINING PROBIOTIC STRAINS, AND METHOD FOR PREPARING SAME - The use of at least one sulphur-containing amino acid, at a total concentration of about 5 to 75 mg/ml, in particular of about 5 to about 50 mg/l, in particular of about 5 to about 30 mg/l, in particular of about 5 to about 20 mg/l, in free form, for implementing a method for preparing a fermented food product fermented by ferments containing bifidobacteria, the food product has acceptable sensory properties, contains more than about 5×1007-05-2012
20120171161COMPOSITIONS COMPRISING PLACENTAL STEM CELLS AND PLATELET RICH PLASMA, AND METHODS OF USE THEREOF - Provided herein are compositions comprising placental stem cells and platelet rich plasma. Also provided herein are methods of treating an individual suffering from a disease or condition that would benefit from reduced inflammation, promotion of angiogenesis, and enhanced healing, comprising administering a therapeutically effective amount of a composition comprising placental stem cells and platelet rich plasma, as described herein, to said individual in an amount and for a time sufficient for detectable improvement of said disease or condition.07-05-2012
20100047209Probiotic composition suitable for animals - The invention provides a probiotic composition to alleviate 02-25-2010
20090068149Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction - The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, 03-12-2009
20110038838Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases - Embodiment include methods for treating cats and dogs with inflammatory bowl disease or inflammatory-like bowl disease or immune mediated hemolytic anemia or atopic dermatitis which are being treated with steroids or immune suppressors which involves the step of administering to the animal a probiotic comprised of 02-17-2011
20110038837COMPOSITION FOR IMPROVING INTESTINAL MICROFLORA - The present invention is to provide a composition for improving the intestinal microflora for maintaining a good intestinal microflora. The present invention consists of a composition for improving the intestinal microflora characterized by containing 02-17-2011
20110223136NUTRITIONAL SUPPORT TO PREVENT AND/OR MITIGATE BONE MARROW TOXICITY FROM A CANCEROUS TUMOR - The present invention relates to methods and immunonutritional compositions for preventing or mitigating paralysis of the bone marrow, caused by a tumor or neoplasm, between cycles of and after anti-cancer therapy, thereby attaining a better efficacy of the treatment. More particularly, the present invention relates to methods and immunonutritional compositions that can transiently preventing or moderating, bone marrow paralysis or neutropenia of a subject tumor-induced apoptosis or necrosis or other cell damage such that the innate and adaptive immune functions and normal physiology of the bone marrow are preserved, at least in part, which, in turn, lead to (i) a better tolerance and increased efficacy to treatment; (ii) transient augmentation or enhancement of immunocompetence of the immune cell; and (iii) optimization of the effects of and increase of immunocompetence of the immune cell weakened due to paralysis of the bone marrow, caused by a tumor or neoplasm.09-15-2011
20120328573Composition for Maintaining Healthy Kidney Function - The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.12-27-2012
20120328572BACILLUS BACTERIA FOR USE IN TREATING AND PREVENTING INFECTION IN AQUATIC ANIMALS - Disclosed herein are microbiocidal compositions that include spore-forming strains of 12-27-2012
20120100108COMPOSITIONS AND METHODS OF TREATING NO-OPTION CRITICAL LIMB ISCHEMIA (CLI) - The present invention provides methods for treating critical limb ischemia (CLI), including increasing wound healing, decreasing wound size, increasing survival-free amputation, preventing amputation, preventing or delaying de novo gangrene, increasing survival probability, and preventing or delaying death, in subjects who prevent a vascular occlusion that cannot be resolved by using a standard method of revascularization, i.e. a subject with “no-option” CLI. Methods of the invention include administering to a subject with no-option CLI an isolated cell composition for tissue repair comprising a mixed population of cells of hematopoietic, mesenchymal and endothelial lineage, wherein the viability of said cells is at least 80% and the composition contains: a) about 5-75% viable CD9004-26-2012
20100203018ZINC-ENRICHED BIOMASS, METHOD FOR THE PREPARATION THEREOF AND PRO-BIOTIC, COSMETIC, DIETARY AND NUTRACEUTIC PRODUCTS COMPRISING THE SAME - The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of 08-12-2010
20130017174COMPOSITIONS AND METHODS FOR INCREASING HEALTH AND REDUCING PATHOGENIC BACTERIA IN ANIMALS - Probiotic compositions comprising a bacterium that is capable of producing nitric oxide and a substrate of nitric oxide synthase are provided. Also provided are methods of improving the gastrointestinal health of a subject by orally administering a bacterium capable of producing nitric oxide and orally administering a substrate of nitric oxide synthase. Methods of reducing the inflammatory immune response after treatment with a probiotic and methods of reducing horizontal transmission of pathogenic bacteria within groups of animals are also provided.01-17-2013
20130022575SYSTEMS AND METHODS OF REPLACING INTESTINAL FLORA - The invention relates to one or more systems and methods for creating a mixture of cultures used to replace intestinal flora. Specifically, the invention relates to methods and systems of treating diseases including 01-24-2013
20130022577PROBIOTIC COMPOSITIONS USEFUL FOR TREATMENT OF BIPOLAR DISORDER - Compositions and methods for treatment or prophylaxis of a bipolar disorder disease state, in which the compositions include the bacilli (1) 01-24-2013
20130022576COMPOSITIONS AND METHODS FOR REDUCING THE INCIDENCE OF EQUINE DIGESTIVE DISORDERS - The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders.01-24-2013
20130171108USE OF ANTI THIRD PARTY CENTRAL MEMORY T CELLS FOR ANTI-LEUKEMIA/LYMPHOMA TREATMENT - A method of treating a disease in a subject in need thereof is disclosed. The method comprising: (a) transplanting a non-syngeneic cell or tissue graft to the subject; and (b) administering to the subject a therapeutically effective amount of an isolated population of cells comprising non-graft versus host (GVHD) inducing anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and capable of homing to the lymph nodes following transplantation, and further wherein the cells are either: (i) non-syngeneic with both the subject and the graft; or (ii) non-syngeneic with the graft and syngeneic with the subject, thereby treating the subject.07-04-2013
20110268702LACTOBACILLUS PARACASEI AND WEIGHT CONTROL - The present invention generally relates to the field of obesity and/or metabolic disorders. In particular the present invention relates to the use of probiotics to treat obesity and/or metabolic disorders. One embodiment of the present invention relates to the use of 11-03-2011
20130095073SKIN PROPERTIES IMPROVING AGENT FOR ORAL ADMINISTRATION - Disclosed is a skin property-improving agent which exerts excellent effects by oral administration. The skin property-improving agent for oral administration contains, as an active ingredient, a bacterium belonging to the genus 04-18-2013
20120276055COMPOSITION CONTAINING BACTERIUM CAPABLE OF PRODUCING PROPIONIC ACID BACTERIUM, AND USE THEREOF - The invention provides a composition that enhances the proliferation activity of propionic acid bacteria in the rumen of ruminants to allow the propionic acid bacteria to sufficiently exhibit their metabolic function in the rumen for the prevention and treatment of rumen acidosis in ruminants. The invention also provides use of the composition. Viable propionic acid bacteria and a lactic acid bacteria culture are orally administered to a ruminant to dramatically (rapidly) promote the proliferation of the propionic acid bacteria in the ruminant rumen, and to thereby increase the volatile fatty acid concentration in the rumen for the prevention and/or treatment of rumen acidosis in the ruminant.11-01-2012
20120276054Alternative bacterial treatment - Alternative treatments are provided for use in the inhibition, decrease, therapeutic or prophylactic support of a 11-01-2012
20120020925Therapeutic Use of Specialized Endothelial Progenitor Cells - The invention relates to products, processes, and therapeutic methods for restoring blood flow to tissues at risk of becoming or being ischemic by inducing angiogenesis and/or vasculogenesis in tissues in need thereof by administering endothelial colony forming cells alone or in combination with other cell types and/or agents. In one aspect, the invention is useful for inducing angiogenesis and/or vasculogenesis in patients with ischemic disease including ischemic heart disease, and other ischemic vascular disorders.01-26-2012
20120027728ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM - The present invention provides an adjunctive agent and a method for lavaging the alimentary canal, which is able to reduce a dose of oral cleaning agent for lavaging the alimentary canal and is capable of realizing an excellent cleaning effect at the time of use of the oral cleaning agent. The adjunctive agent comprises butyric acid bacterium (for example, 02-02-2012
20130202561METHOD OF TREATING DRAINS USING FUNGUS CULTURES - A method of treating drain systems containing organic matter and providing a biopesticide for killing insects is provided. The method comprises introducing into a drain system a bacterial culture, such as 08-08-2013
20130202562LIQUID MICROORGANISM CONSORTIA FORMULATION - The present invention is directed to compositions and methods using microorganisms to benefit an environment or recipient subject. The present invention relates to the use of microorganism based compositions and methods to enhance the health of recipient subjects, improve soil conditions, and accelerate biodegradation. The present invention also relates to controlling insect and pest populations. Further, the present invention relates to the replacement of chemical compositions with microorganism based compositions.08-08-2013
20120093779COMPLEX MICROBIAL PREPARATION FOR TREATING DIABETES AND PREPARATIVE METHOD AND USE THEREOF - A complex microbial preparation comprises (in vol. %): 04-19-2012

Patent applications in class Intentional mixture of two or more micro-organisms, cells, or viruses of different genera